Evidence at a glance
Status and evidence table
| Peptide | Canada status | Human evidence |
|---|---|---|
| BPC-157 | Not authorized in Canada | Very limited: almost all animal or cell studies |
| TB-500 and Thymosin Beta-4 | Not authorized in Canada | Very limited: almost all animal or cell studies (TB-500); small trials of Tβ4 eye drops |
Status reflects Health Canada's peptide pages, its April 2026 advisory and the Drug Product Database as checked on November 10, 2026. Authorized products carry an 8-digit DIN (drugs) or NPN (natural health products).
